Top Stories

Stroke survivors get FDA-approved daily pill shown to cut repeat risk by 26%

Nov 14, 2026 at 6:30 AM MST Source: FOX 0 views 0 comments

Sunharbo (asundexian) is the first FDA-approved factor XIa inhibitor for secondary stroke prevention, but key limitations and risks do remain. Read more at FOX ›

Read the full story at

FOX

Open the original

The Gadsden Report aggregates and summarises headlines. The reporting above belongs to FOX, and the link opens their page. This page exists so readers can find, share, and discuss the story here.

Ford privacy promise raises questions about your car data

Play Sunday or forfeit: Oklahoma AD rips SEC commissioner over controversial Ole Miss FAA scheduling decision [FOX]

Taxpayer-Funded Library Welcomes Cop Killers And Bombers For Radical ‘Mentorship’ Event [DAILY WIRE]

Weekend Plans With Former ‘Bachelor’ Host Chris Harrison, Who Never Gave Up On Happily Ever After [DAILY WIRE]

Sexual predator deported to Mexico hauled back to US for assault and murder of American mom [FOX]

Restaurant chain may rethink controversial 20% service charge in some venues after customer pushback

Discussion — 0 comments

No comments yet. Be the first.